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Abstract
Background: The angiogenic and invasive properties of the cytotrophoblast are crucial to provide an
adequate area for feto-maternal exchange. The present study aimed at identifying the localization of
interrelated angiogenic, hyperpermeability and vasodilator factors in the feto-maternal interface in
pregnant guinea-pigs.
Methods: Utero-placental units were collected from early to term pregnancy. VEGF, Flt-1, KDR, B2R and
eNOS were analyzed by immunohistochemistry, and the intensity of the signals in placenta and syncytial
streamers was digitally analysed. Flt1 and eNOS content of placental homogenates was determined by
western blotting. Statistical analysis used one-way analysis of variance and Tukey's Multiple Comparison
post-hoc test.
Results: In the subplacenta, placental interlobium and labyrinth VEGF, Flt-1, KDR, B2R and eNOS were
expressed in all stages of pregnancy. Syncytial streamers in all stages of gestation, and cytotrophoblasts
surrounding myometrial arteries in early and mid pregnancy – and replacing the smooth muscle at term –
displayed immunoreactivity for VEGF, Flt-1, KDR, eNOS and B2R. In partly disrupted mesometrial arteries
in late pregnancy cytotrophoblasts and endothelial cells expressed VEGF, Flt-1, KDR, B2R and eNOS.
Sections incubated in absence of the first antibody, or in presence of rabbit IgG fraction and mouse IgG
serum, yielded no staining. According to the digital analysis, Flt-1 increased in the placental interlobium in
days 40 and 60 as compared to day 20 (P = 0.016), and in the labyrinth in day 60 as compared to days 20
and 40 (P = 0.026), while the signals for VEGF, KDR, B2R, and eNOS showed no variations along
pregnancy. In syncytial streamers the intensity of VEGF immunoreactivity was increased in day 40 in
comparison to day 20 (P = 0.027), while that of B2R decreased in days 40 and 60 as compared to day 20
(P = 0.011); VEGF, Flt-1, KDR, B2R and eNOS expression showed no variations. Western blots for eNOS
and Flt-1 in placental homogenates showed no significant temporal differences along pregnancy.
Conclusion: The demonstration of different angiogenic, hyperpermeability and vasodilator factors in the
same cellular protagonists of angiogenesis and invasion in the pregnant guinea-pig, supports the presence
of a functional network, and strengthens the argument that this species provides an adequate model to
understand human pregnancy.
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Background
The successful evolution of pregnancy requires finely
tuned adaptations to permit an adequate exchange
between fetal and maternal blood. On one hand, the fetal
and maternal circulations establish close contact in the
progressively extended and thin vascular structure of the
placenta. On the other, utero-placental blood flow
increases progressively, by transformation of the uterine
arteries into large bore non-reactive vessels, achieved by
cytotrophoblasts that disrupt the smooth muscle of the
uterine arteries and replace their endothelium. Thus, both
the angiogenic and invasive properties of the cytotro-
phoblast are critical in determining the fate of pregnancy
[1-6].
Vascular endothelial growth factor (VEGF) seems to be
fundamental to placentation. It is expressed in the utero-
placental interface of several species [7-13], in humans
localizes mainly in the invading front of anchoring col-
umns and in endovascular cytotrophoblasts, is down reg-
ulated in preeclampsia, and the blockade of its binding
decreases cytotrophoblast expression of integrin α1, and
increases apoptosis [14]; its removal from culture
medium induces massive apoptosis of uterine microvas-
cular endothelial cells [15]. Moreover, VEGF receptor
knockout mice have a high embryonic lethality associated
to defective angiogenesis [16,17]. VEGF could also
increase vascular permeability in the endometrium, as
demonstrated for tumoral cells [18]. Later, localized in
perivascular trophoblasts, could through its vasodilator
effect prime the uterine arteries for invasion, as has been
suggested for NO [19], enhancing their high blood flow.
The pluripotential effects of VEGF are exerted by the acti-
vation of its two receptors, Flt-1 and KDR [20,21]. Of
these, KDR can be the sole mediator of the physiological
and pathological effects of VEGF, being capable of pro-
moting angiogenesis and hyperpermeability in vivo. Flt-1
modulates KDR, preventing the excessive and disorgan-
ized formation of endothelial cells, promotes migration
of endothelial cells, and upregulates the expression of
MMP-9 [22]. In humans VEGF receptors are expressed in
anchoring columns, are upregulated within their first cell
layers and downregulated in severe preeclampsia and in
the hemolysis, elevated liver enzymes and low platelet
(HELLP) syndrome. In vitro inhibition of ligand binding
to these receptors decreases cytotrophoblast invasion
[14]. Both Flt-1 and KDR trigger a cascade that activates
eNOS, via phosphatidilinositol 3-kinase and phospholi-
pase Cγ1 respectively [20,23,24] (Figure 1). The release of
NO, considered a second messenger for VEGF-driven ang-
iogenesis with its consequent vasodilation, represent ini-
tiating events in sprouting angiogenesis [21].
Bradykinin is also a potent stimulus of eNOS, and NO
production, through Ca 2+  mediated mechanisms.
Depending on the cell types, it can induce proliferative or
antiproliferative effects, and appears to be an important
agent in ischemia-induced angiogenesis [25]. The two
cognate receptors of the kallikrein-kinin system are the
type-1 and type-2 receptors (B1R and B2R), being the B2R
ubiquitous and the main receptor of the classical effects of
kinins (vasodilation, hyperpermeability), in contrast to
the B1R, which is involved in tissue injury, reaction to
cytokines or microbial products. The effects of VEGF are
also enhanced by bradykinin [26,27].
The present study aims at demonstrating the localization
and the variations in the expression of VEGF, Flt-1, KDR,
B2R and eNOS along pregnancy in guinea-pigs. We
hypothesize that the localization of these functionally
interrelated factors supports a network of angiogenic,
hyperpermeability and vasodilator factors (Fig. 1), that
participates in placental angiogenesis and cytotrophoblast
invasion.
The pregnant guinea-pig was used in this study as it shares
with the human utero-placental interfase a series of simi-
larities, as a hemomonochorial structure, a subplacenta
that resembles the anchoring villi as a source of extravil-
lous trophoblasts, a decidual invasion and a transforma-
tion of the uterine arteries into low resistance high flow
vessels [28-30]. Apart from the morphofunctional similar-
ities, this species helps to circumvent the ethical and tech-
nical constraints that hinder the sequential study of
normal or deranged human pregnancy.
We describe the expression of VEGF, Flt-1, KDR, B2R and
eNOS in the same cell types of the feto-maternal interface
of the guinea-pig, the subplacenta, the interlobar and lab-
yrinthine placenta, syncytial streamers, peri and intravas-
cular cytotrophoblasts, and fetal and maternal
endothelial cells. This study supports our hypothesis for a
functional role of this angiogenic, hyperpermeability and
vasodilator network.
Methods
Guinea-pigs (Pirbright white ~600 g) were kept under
controlled humidity, temperature, and a 12-hour light:
dark cycle. The animals were fed with Xtravital Special
Food for Cavies (Beaphar, Holland) and supplemented
with ascorbic acid in the drinking water. Litter size varied
from 2–5 fetuses. Females were examined daily, and when
vaginal opening was observed they were caged with fertile
males. The day in which a vaginal plug, or sperms were
observed in vaginal smears, was defined as day one of
pregnancy. The experiments were approved by the IRB,
and conducted according to the Guide for the Care and Use
of Laboratory Animals (National Research Council, USA).Reproductive Biology and Endocrinology 2008, 6:13 http://www.rbej.com/content/6/1/13
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The animals were deeply anesthetized with a mixture of
ketamine (100 mg/kg) and xylazine (4 mg/kg) given
intraperitoneally. Twenty dams were sacrificed in early
(15, 20 days), mid (30, 45 days) and term (60 days) preg-
nancy (≈ length of pregnancy in the guinea-pig 63 days).
The uterus and feto-placental units were removed; in
some units a central slice through the placenta, subpla-
centa, implantation site and underlying myometrium was
fixed as a single block; in other units, the placenta,
endometrium, and mesometrium were separately dis-
sected. The animals were euthanized with an overdose of
anesthetic. Tissues were fixed immediately with phos-
phate-buffered 4% formalin for 24 h. The fixed tissues
were dehydrated in a graded series of ethanol and xylene,
and embedded in Paraplast-Plus® (Sigma, St. Louis, MO).
Serial sections (5 μm) were mounted on silanized slides.
Immunostaining procedure
All immunostaining procedures were performed at room
temperature; deparaffinized sections were rehydrated
through ethanol and methanol, rinsed three times for five
minutes in PBS-50 mM Tris-HCl pH 7.8 and submitted to
Signaling pathways that contribute to VEGF induced angiogenesis, and a proposal for their participation in the development of  the utero-placental interface by participating in proliferative, invasive, vasodilatory and permeability changes essential for cell  invasion and angiogenesis Figure 1
Signaling pathways that contribute to VEGF induced angiogenesis, and a proposal for their participation in the 
development of the utero-placental interface by participating in proliferative, invasive, vasodilatory and per-
meability changes essential for cell invasion and angiogenesis. VEGF activates eNOS through pathways including Akt/
PKB, Ca+2/CaM, and PKC [20-24]. Flt-1 may negatively regulate KDR, but might also promote its activity [20]. Bradykinin stim-
ulates eNOS through Ca+2, induces EC to form tubes, and transactivates the KDR [26]. The factors studied have been depicted 
in orange areas surrounded by a red border, known mechanisms of downstream activation by interrupted arrows, and 
unknown mechanism of downstream activation by interrupted arrow. VEGF, vascular endothelial growth factor; BK, bradyki-
nin; eNOS, endothelial nitric oxide synthase; PLC β, phospholipase C -β; PLCγ, phospholipase C -γ; DAG, diacylglycerol; IP3, 
inositol (1,4,5)-triphosphate; PKC, protein kinase C; MAPK, mitogen-activated protein kinase; FAK, focal adhesion kinase; 
PI3K, phosphoinositide 3-kinase; p38 MAPK, p38 mitogen-activated protein; Erk, extracellular regulated kinase; HSP27, heat 
protein; CaM, calmodulin; EC, endothelial cell.
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heat antigen retrieval using citrate buffer pH 6.0 for eNOS,
VEGF, Flt-1 and KDR, cytokeratin and von Willebrand fac-
tor, and Tris-HCl-EDTA pH 9.0 for muscle actin and
cytokeratin-7. Endogenous peroxidases were blocked by
incubating in 10% H2O2 for 20 minutes. Sections were
incubated in a humid chamber for 30 minutes with pro-
tein block (Cas-Block®, Zymed, San Francisco, CA) fol-
lowed by incubation for 18 h at 4°C with the primary
antibodies: mouse monoclonal anti-eNOS (1:50, clone 3
BD Transduction Laboratories), VEGF (1:50, clone JH
121, Upstate); rabbit polyclonal KDR (1:500, Upstate)
and Flt-1 (1:1000, Santa Cruz Biotechnology, Inc). The
B2R antibody (1:4000), mixture of 8 polyclonal rabbit
antisera that recognizes the various domains of the recep-
tor, was raised against the rat kinin B2R, and was kindly
donated by Dr. Werner Müller-Esterl, Frankfurt Univer-
sitäts, Germany [31].
Sections were immunostained using a biotin-streptavidin-
peroxidase system (DakoCytomation, Carpinteria, CA).
Finally, the samples were incubated for 15 minutes with
0.1% (w/v) 3-3'-diaminobenzidine in buffer containing
0.05% H2O2. The slides were counterstained with Harris
hematoxylin (Sigma, St. Louis, MO).
Cytotrophoblasts were identified by staining with an anti-
pancytokeratin mouse monoclonal antibody (1:100,
P2871, Sigma, St. Louis, MO), and in addition by cytoker-
atin 7-specific antibody (1:10, Clone OV-TL/12/30 Dako-
Cytomation) that binds to all trophoblast populations
and epithelial cells, and displays no reactivity for mesen-
chymal cells [32]. Smooth muscle and endothelial cells
were characterized with antibodies against muscle actin
(clone HHF35, 1:1000) and von Willebrand factor
(A0082, 1:400) both obtained from DakoCytomation.
The specificity of the staining was determined by incuba-
tion of sections in the absence of the first antibody, or in
the presence of rabbit IgG fraction (1:100 and 1:4000)
and mouse IgG serum (1:50), both from Dako Cytoma-
tion.
Digital image analysis
The immunostained sections of the placenta and
endometrium were photographed with a Nikon CoolPix
4500 camera (Nikon Inc., Tokyo, Japan) coupled to a
Zeiss AxioImager AX.10 microscope (Carl Zeiss, CA) using
a 20× and 40× objectives [33].
The immunohistochemical expression of VEGF, Ft1-1,
KDR, eNOS and B2R was digitally analyzed in a total of
fifteen fields from each placenta and endometrium, which
were photographed from five sections per dam, in three
animals in each of the following periods: early (20 days),
mid (40 days) and term (60 days) pregnancy. The images
were loaded into the ImageJ v.1.34 software (National
Institutes of Health, Bethesda, MD) for analysis. A total of
243 syncytial streamers were manually delineated,
extracted from the surrounding tissue to a separate image
file and saved in JPEG format. Immunoreactive signals
were extracted from the images with a color deconvolu-
tion algorithm [34], integrated in the ImageJ software.
After conversion of pixel luminosity values to an optical
density scale, the integrated optical density was measured
in the previously extracted positive staining images and
normalized by the positive area in each microphotograph.
The signal intensity (I) was calculated as I = 10·∑OD/A in
dB/μm2, being ∑OD the integrated optical density, and A
the area of positive staining (μm2) [35].
Protein extraction
Total proteins from placenta from early, mid and term
pregnancy were extracted using 5 ml/g of 20 mM Tris-HCl
buffer containing 10 mM EDTA, 2 mM phenylmethylsul-
fonylfluoride, 5 μM leupeptin, 50 μg/ml soybean trypsin
inhibitor, 0.05% Brij-35 and 0.02% NaN3 at pH 7.4. Tis-
sues were homogenized with a Tekmar Tissumizer
(Cincinnati, OH) for one minute on ice. Crude homoge-
nates were centrifuged at 4000 rpm for 20 minutes, then
0.2% SDS was added to the supernatant, kept for 1 hour
at 4°C, centrifuged at 14000 rpm for 20 min at 4°C and
finally stored at -70°C. Protein content was determined
according to the Lowry method [36].
Western blot analysis
Equal amounts of protein (100 μg/lane) were separated
using 10% SDS-PAGE under reducing conditions and
transferred to nitrocellulose membranes (Biorad, Her-
cules, CA), blocked with 3% nonfat dry milk in PBS-0.1%
Tween-20 buffer (PBS-T) and incubated overnight at 4°C
with the same primary antibodies used in immunohisto-
chemistry: mouse monoclonal anti-eNOS (1: 1000, clone
3 BD Transduction Laboratories) and rabbit polyclonal
Flt-1 (1: 200, Santa Cruz Biotechnology, Inc) diluted in
blocking buffer.
The membranes were washed three times for five minutes
in PBS-T buffer, incubated with HRP-conjugated anti-
mouse or anti-rabbit secondary antibodies (both 1:3000,
Biorad, Hercules, CA) for one hour at room temperature
and developed with chemiluminescence reagent (NEL-
103, Western Lighting, Perkin-Elmer, MA) [36,37]. Mem-
branes were exposed to CL-xPosure film (Pierce, Rock-
ford, IL). Equal protein loading (100 ug/lane) was
confirmed with Ponceau-S red staining (Sigma, St. Louis,
MO). Images were scanned at 16-bit/600 dpi resolution
with an Epson Perfection 3490 scanner (Epson Corpora-
tion, CA), saved as tiff files and calibrated to an optical
density scale. The integrated optical density of bands was
quantitated using the ImageJ v.1.34 software.Reproductive Biology and Endocrinology 2008, 6:13 http://www.rbej.com/content/6/1/13
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Purified human Flt-1 and eNOS yielded bands with
approximate molecular weights of 180 and 140 kDa
respectively [38,39].
Statistical analysis
Overall differences between the three studied periods of
pregnancy were assessed with SPSS v 10 (SPSS Inc., Chi-
cago, IL) using the one-way analysis of variance and
Tukey's Multiple Comparison post-hoc test. P < 0.05 was
chosen as significance level for all analyses performed.
Results are expressed as means ± SEM.
Results
Spatio-temporal expression of VEGF, Flt-1, KDR, B2R and
eNOS in utero-placental units.
Subplacenta
The plied multilayered subplacenta represented the main,
if not the exclusive, source of trophoblasts, as syncytial
sprouts could be observed as early as day 15 of gestation
emerging from its abluminal side to penetrate the first
inner third of the endometrium. In addition, syncytiotro-
phoblast buds, emerging from the luminal side, consti-
tuted the earliest expression of the subplacenta. At this
early stage, and throughout pregnancy, the subplacental
syncytiotrophoblasts expressed granular immunoreactiv-
ity for VEGF, Flt-1, KDR, B2R and eNOS (Fig. 2).
Placenta
From day 15 of pregnancy to term trabeculae and syncyti-
otrophoblast plates, originating from the subplacenta,
expressed immunoreactivity for VEGF, Flt-1, KDR, B2R
and eNOS, as granules in the thick bands of syncytiotro-
phoblast of the interlobium; in the labyrinth immunore-
activity for all factors displayed a diffuse reaction in the
thin syncytial trabeculae and a thin lineal one in the
endothelial cells. The cellular density of the interlobium
showed a mild increase as pregnancy progressed, while
that of the labyrinth increased markedly between days 40
and 60 as compared to day 20 (Fig. 3).
The digital quantification of the reactivity showed that in
the interlobium Flt-1 increased in days 40 and 60 (10.4 ±
0.62 and 10.2 ± 0,23 dB/μm2 respectively), as compared
to day 20 (8.3 ± 0.10 dB/μm2; P = 0.016), and in the lab-
yrinth in day 60 (10.6 ± 0.32 dB/μm2), as compared to
days 20 and 40 (7.9 ± 0.83 and 10.0 ± 0.20 dB/μm2
respectively; P = 0.026). VEGF showed no variations in the
interlobium or labyrinth (Fig. 3). KDR, B2R, and eNOS
(not shown) displayed no changes. Western blots of pla-
cental homogenates showed no significant differences for
Flt-1 and eNOS (Fig. 4).
Endometrium
As early as day 15 of gestation, VEGF in cytokeratin posi-
tive cells was expressed in pericytes, and in invasive tro-
In subsequent sections of a utero-placental unit obtained in day 15 of pregnancy, the multilayered subplacenta (SP) gave rise to  the placental sprouts, and to the syncytial streamers that penetrate the adjacent decidua Figure 2
In subsequent sections of a utero-placental unit obtained in day 15 of pregnancy, the multilayered subplacenta 
(SP) gave rise to the placental sprouts, and to the syncytial streamers that penetrate the adjacent decidua. The 
subplacenta, the placental sprouts and the syncytial streamers expressed VEGF, Flt-1, KDR, B2R and eNOS. Cytotrophoblasts 
were characterized by cytokeratin (CK) staining. Bar = 100 μm.
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phoblasts coalescing into syncytial streamers that
migrated into the endometrium. Intraluminal plugs were
observed in some arteries from day 20 onwards (not
shown).
VEGF, Flt-1, KDR, B2R and eNOS immunoreactivity in
syncytial streamers showed a granular staining (Fig. 5).
Quantification by digital analysis showed an increased
VEGF expression in day 40 (10.1 ± 0.8 dB/μm2) in com-
parison to day 20 (6.8 ± 0.7 dB/μm2; P = 0.027), while
B2R decreased in days 40 (7.3 ± 0.4 dB/μm2) and 60 (7.6
± 0.1 dB/μm2) as compared to day 20 (9.4 ± 0.5 dB/μm2;
P = 0.011); no differences were observed for Flt-1, KDR
and eNOS.
Syncytial streamers were observed in the periphery of
large decidual blood vessels near the subplacenta in mid
and term pregnancy. In early pregnancy syncytial stream-
ers were long thin projections of multinucleated trophob-
lasts. In mid pregnancy they formed thick and short
aggregations, and in late pregnancy surrounded the arter-
ies. Intramural cytotrophoblasts expressed all studied fac-
tors, as shown for VEGF and eNOS (Fig. 6).
Myometrial and mesometrial arteries
Myometrial arteries showed an intact thick (30 days) or a
thin, partly disrupted (45 days) vascular smooth muscle
layer, and were surrounded by cytotrophoblasts express-
ing VEGF. VEGF was also observed in swollen endothelial
cells at 45 and 60 days. In late pregnancy cytotrophoblasts
almost replaced the smooth muscle layer, attained the
luminal border; and presented a granular staining for
Syncytial streamers (ST) in the subplacenta (SP) and in the  decidua expressed VEGF, Flt-1, KDR, B2R and eNOS in days  20, 40 and 60 of pregnancy Figure 5
Syncytial streamers (ST) in the subplacenta (SP) and 
in the decidua expressed VEGF, Flt-1, KDR, B2R and 
eNOS in days 20, 40 and 60 of pregnancy. Bar = 100 
μm. Rectangle defines the area shown at a higher magnifica-
tion (400×) in Figure 6.
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Syncytiotrophoblasts composing the interlobium and the lab- yrinth expressed Flt-1 and VEGF, in sections obtained in days  20, 40 and 60 of pregnancy at a high magnification (1000×) Figure 3
Syncytiotrophoblasts composing the interlobium and 
the labyrinth expressed Flt-1 and VEGF, in sections 
obtained in days 20, 40 and 60 of pregnancy at a high 
magnification (1000×). The immunoreactivity showed a 
granular pattern for interlobar Flt-1, and for interlobar and 
labyrinthine VEGF; labyrinthine Flt-1 displayed a diffuse cyto-
plasmic staining. Arrowheads highlight linear signal in 
endothelial cells. Bar = 100 μm.
Representative blot of placental homogenates from days 20,  40 and 60 of pregnancy for FLT-1 and eNOS Figure 4
Representative blot of placental homogenates from 
days 20, 40 and 60 of pregnancy for FLT-1 and eNOS. 
Purified human Flt-1 and eNOS yielded bands with approxi-
mate molecular weights of 180 and 140 kDa respectively. No 
significant differences were observed between the means of 
the 3 homogenates included in each study period, using one-
way analysis of variance and Tukey's Multiple Comparison 
post-hoc test.
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VEGF (Fig. 7). Flt-1, KDR, eNOS and B2R had a similar
expression than that of VEGF along the different stages of
pregnancy (not shown).
Mesometrial arteries in early (20 days) and mid (40 days)
pregnancy had a thick multilayer of smooth muscle cells
and no trophoblasts were observed in their periphery or
within the muscle layer. At term pregnancy (60 days)
cytotrophoblasts replaced part of the muscle layer, and
presented a positive signal for VEGF, Flt-1, KDR, B2R and
eNOS. Swollen endothelial cells, identified by vWF, also
expressed VEGF, Flt-1, KDR, B2R and eNOS (Figure 8).
Control sections incubated with rabbit and mouse non-
specific immunoglobulin (Figure 9), or in absence of the
first antibody (not shown), yielded no staining in differ-
ent structures and stages of pregnancy.
Discussion
The present study provides the first demonstration that
VEGF, its receptors Flt-1 and KDR, eNOS and the B2R,
angiogenic, vasodilatory and hyperpermeability factors,
are expressed in the same cell types of the guinea-pig feto-
maternal interface along pregnancy. We postulate that
these functionally interrelated factors represent a network
that participates in placental angiogenesis and trophob-
last invasion in an autocrine/paracrine way [1].
We will now analyze the potential effect of these factors
regarding the development and maintenance of the utero-
placental unit. The development of the placenta from
endothelial cell precursors in the first syncytial buds
requires enhanced vascular permeability, a consistent fea-
ture of angiogenesis; leaky vessels extravasate fibrinogen
and plasminogen, which clotting into crosslinked fibrin
and plasmin respectively, could favor endothelial cell
adhesion and migration, as for tumoral cells [18]. Plas-
min could activate MMPs, and in addition to kallikrein
also present in utero-placental units in guinea-pigs [33],
could participate in basement membrane degradation.
Once the placenta is developed, the anticoagulating effect
of NO and bradykinin could prevent platelet aggregation
in its intricate vascular spaces, favorable targets for platelet
aggregation.
In the attachment and implantation stages, the increased
vasodilatation of uterine blood vessels in the implanta-
tion sites probably increases blood flow to meet the
demands of oxygen and nutrients of the embryo, prior to
the development of the placental bed. It seems feasible
that subplacental VEGF, bradykinin, and NO could gener-
ate edema, a prominent feature of decidualization, and
jointly with changes in extracellular matrix could facilitate
Spiral arteries observed in sequential sections of myo- metrium obtained in days 30, 45 and 60 of pregnancy Figure 7
Spiral arteries observed in sequential sections of 
myometrium obtained in days 30, 45 and 60 of preg-
nancy. Cytokeratin positive trophoblasts expressed VEGF. 
The remaining vascular smooth muscle layers were positive 
for muscle actin (MA), and have been almost replaced in day 
60. Bar = 100 μm.
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Syncytial streamers (arrows) in the vicinity of a decidual  blood vessel in late pregnancy displayed granular VEGF and  eNOS reactivity, and a linear pattern for cytokeratin-7 in the  syncytial membrane Figure 6
Syncytial streamers (arrows) in the vicinity of a 
decidual blood vessel in late pregnancy displayed 
granular VEGF and eNOS reactivity, and a linear pat-
tern for cytokeratin-7 in the syncytial membrane. 
Intramural cytotrophoblasts (arrowheads) near the vessel 
lumen also expressed a granular eNOS reactivity, and intense 
intracytoplasmatic cytokeratin-7 staining. Bar = 100 μm.
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trophoblast penetration of the underlying endometrium.
The subsequent propagation of syncytial streamers could
convey these effects to the deeper decidua, to finally facil-
itate disruption of the arterial wall. In the vicinity of uter-
ine arteries these factors could prime the maternal vessels
for invasion by relaxing smooth muscle cells and increas-
ing arterial compliance, as proposed by Nanaev and
cols[19].
Our observations on the localization of eNOS extend
those of Nanaev and cols. who described positive eNOS
extravillous trophoblasts extending from the junctional
zone into the myometrium, as well as in those surround-
ing mesometrial arteries and replacing endothelial cells.
Our finding of VEGF, eNOS and B2R in syncytial stream-
ers supports a similar role in priming of spiral arteries. In
comparison from a recent studies of Kaufmann and cols.,
and Bosco and cols., we were unable to recognize the iso-
lated invasive extravillous trophoblasts described in the
transitional zone lateral to the subplacenta of the guinea-
pig and degu [30,40]. These trophoblasts are reported to
be cytokeratin negative while traversing the
endometrium, and thus are hard to identify; we postulate
that these are later represented by intramural cytotro-
phoblasts, which having switched their phenotype are
able to express cytokeratin and the panel of factors here
studied.
Several factors may be responsible for the discrepancy
between the significant temporal variations observed in
immunohistochemistry and the absence of changes
observed in western blotting. First, the inherent differ-
ences of both techniques; while immunohistochemistry
depends on the exposition of the epitopes, thus on the
conformation of the protein, western blotting depends on
its solubility and integrity along the stages of homogeni-
zation. However, both methods complement each other;
while placental homogenates including interlobium and
labyrinth demostrated proteins with the equivalent
weights of Flt-1 and eNOS, the immunohistochemistry
determined the protein expression in each of the different
zones. Though the discrepant findings between both
methods pose the need to pursue the characterization of
the temporal variations, the immmunohistochemistry
suggests an upregulated expression of Flt-1 in the interlo-
bium in mid and late gestation and in the labyrinth near
term, as well as of VEGF and the B2R in syncytial stream-
ers in early and mid gestation.
Mesometrial arteries obtained in days 20 and 40 of pregnancy showed in sequential sections an intact smooth muscle layer  characterized by muscle actin (MA), and no cytokeratin positive cells Figure 8
Mesometrial arteries obtained in days 20 and 40 of pregnancy showed in sequential sections an intact smooth 
muscle layer characterized by muscle actin (MA), and no cytokeratin positive cells. In day 60, intramural trophob-
lasts, characterized by cytokeratin (CK), expressed VEGF, Flt-1, KDR, B2R and eNOS, as did the swollen endothelial cells, 
identified by von Willebrand Factor (vWF). The remaining vascular smooth muscle, positive for muscle actin (MA), was dis-
rupted. Bar = 100 μm.
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In vivo and in vitro studies in the guinea-pig need to be
done to evaluate the individual importance of the factors
here described. The alterations induced by interfering
with VEGF through the soluble form of Flt-1 (sFlt-1)
[41,42], the decrease in cytotrophoblast invasion and
expression of integrin α 1 [14] and the increased apopto-
sis by inhibition of the ligand binding of VEGF have
proven the functional relevance of its pathway. The
importance of the nitridergic system has been confirmed
by the blockade of eNOS with L-NAME [43-45]. Altera-
tions in pregnancy in Brown Norway rats [46], a strain
with a defective kallikrein-kinin system [47], and the high
predictive index of preeclampsia of low urinary kallikrein
in early human pregnancy [48], suggest that a deficient
kallikrein-kinin system may hinder the local adaptations
of pregnancy, thus its functional role deserves to be eluci-
dated.
In humans, immunoreactive VEGF, Flt-1, KDR [8,49] and
eNOS [50-55] have been detected in villous cyto and syn-
cytiotrophoblasts, fetal capillaries, and in extravillous tro-
phoblasts; moreover, the B2R has been described in these
cell types, and in addition in intraarterial trophoblasts
[51]. The localization of these factors in placental syncyti-
otrophoblasts, fetal endothelial cells, and invading tro-
phoblasts in the guinea-pig, bears a concordance with that
described for cell types that in the human morphologi-
cally and functionally resemble the placental syncytium
and endothelium, and the invasive trophoblasts.
Conclusion
The expression of angiogenic, permeability enhancers and
vasodilatory factors in the human and guinea-pig utero-
placental interface supports for them complex, and per-
haps redundant, interrelated functional roles. Moreover,
this study underscores the importance of the model of the
pregnant guinea-pig to understand human pregnancy.
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